scholarly article | Q13442814 |
P356 | DOI | 10.1002/GLIA.20287 |
P8608 | Fatcat ID | release_fkswtrhxunbapaw6o5wtg4z7li |
P698 | PubMed publication ID | 16267833 |
P5875 | ResearchGate publication ID | 7499914 |
P50 | author | Lawrence Moon | Q58232906 |
P2093 | author name string | Mary Bartlett Bunge | |
Patrick M Wood | |||
Caitlin E Hill | |||
P2860 | cites work | Transient immunosuppression stops rejection of virus-transduced enhanced green fluorescent protein in rabbit retina. | Q40161594 |
Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury | Q44832747 | ||
Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord. | Q45883608 | ||
BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury | Q46052857 | ||
Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. | Q48525862 | ||
Use of a rat Y chromosome probe to determine the long-term survival of glial cells transplanted into areas of CNS demyelination | Q48735273 | ||
Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival. | Q50510445 | ||
Ubiquitous expression of marker transgenes in mice and rats. | Q52174452 | ||
Temporal–Spatial Pattern of Acute Neuronal and Glial Loss after Spinal Cord Contusion | Q59468421 | ||
Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury | Q71694664 | ||
Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration | Q80973434 | ||
P433 | issue | 3 | |
P921 | main subject | Schwann cell | Q465621 |
P304 | page(s) | 338-343 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | Glia | Q15716658 |
P1476 | title | Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival | |
P478 | volume | 53 |
Q37595313 | 17β-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury |
Q34254821 | A calpain inhibitor enhances the survival of Schwann cells in vitro and after transplantation into the injured spinal cord |
Q35127777 | A systematic review of cellular transplantation therapies for spinal cord injury |
Q35809691 | An overview of tissue engineering approaches for management of spinal cord injuries |
Q28475604 | Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery |
Q38616866 | Attenuation of Oxidative Stress-Induced Cell Apoptosis in Schwann RSC96 Cells by Ocimum Gratissimum Aqueous Extract |
Q35071889 | Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury. |
Q41851504 | Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries |
Q39261219 | Cell transplantation therapy for spinal cord injury. |
Q36956709 | Cellular approaches for stimulating CNS remyelination |
Q24630772 | Cellular treatments for spinal cord injury: the time is right for clinical trials |
Q37476168 | Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord |
Q53410201 | Combined effects of rat Schwann cells and 17β-estradiol in a spinal cord injury model. |
Q26861926 | Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review |
Q89179338 | Decellularized peripheral nerve supports Schwann cell transplants and axon growth following spinal cord injury |
Q36227419 | Differential effects of distinct central nervous system regions on cell migration and axonal extension of neural precursor transplants |
Q38809907 | Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? |
Q57997786 | Efficient Generation of Schwann Cells from Human Embryonic Stem Cell-Derived Neurospheres |
Q36464568 | Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia |
Q54654209 | Functional and Histological Improvement of the Injured Spinal Cord Following Transplantation of Schwann Cells Transfected With NRG1 Gene |
Q41016467 | Grafted Activated Schwann Cells Support Survival of Injured Rat Spinal Cord White Matter. |
Q47876397 | Human Schwann cells exhibit long-term cell survival, are not tumorigenic and promote repair when transplanted into the contused spinal cord |
Q35737471 | Human Schwann cells retain essential phenotype characteristics after immortalization |
Q38784001 | Human dental pulp stem cells expressing STRO-1, c-kit and CD34 markers in peripheral nerve regeneration. |
Q37664162 | Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury. |
Q34385587 | Long-term survival, axonal growth-promotion, and myelination of Schwann cells grafted into contused spinal cord in adult rats |
Q27312623 | MASH1/Ascl1a leads to GAP43 expression and axon regeneration in the adult CNS |
Q55111012 | Macrophage depletion and Schwann cell transplantation reduce cyst size after rat contusive spinal cord injury. |
Q37134181 | Morphological characteristics of apoptosis and its significance in neurogenesis |
Q35613352 | Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury |
Q37471457 | Multiple channel bridges for spinal cord injury: cellular characterization of host response. |
Q26797407 | Myelin damage and repair in pathologic CNS: challenges and prospects |
Q48172017 | Myelinogenic Plasticity of Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury |
Q47980734 | Noninvasive bioluminescence imaging of olfactory ensheathing glia and schwann cells following transplantation into the lesioned rat spinal cord |
Q36932263 | Novel combination strategies to repair the injured mammalian spinal cord. |
Q46775449 | Olfactory ensheathing cells do not exhibit unique migratory or axonal growth-promoting properties after spinal cord injury. |
Q37299595 | P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord |
Q28071648 | Peripheral Nerve Injury: Stem Cell Therapy and Peripheral Nerve Transfer |
Q52626491 | Peripheral nerve repair with cultured schwann cells: getting closer to the clinics. |
Q57816233 | Polycaprolactone electrospun fiber scaffold loaded with iPSCs-NSCs and ASCs as a novel tissue engineering scaffold for the treatment of spinal cord injury |
Q83292612 | Promoting survival, migration, and integration of transplanted Schwann cells by over-expressing polysialic acid |
Q90738658 | Recent advances in nanotherapeutic strategies for spinal cord injury repair |
Q64981683 | Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds. |
Q37227963 | Resection of glial scar following spinal cord injury |
Q38247993 | Role of endogenous Schwann cells in tissue repair after spinal cord injury |
Q92240715 | Schwann Cell-Like Cells Derived from Human Amniotic Mesenchymal Stem Cells Promote Peripheral Nerve Regeneration through a MicroRNA-214/c-Jun Pathway |
Q36858361 | Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice. |
Q83475978 | Schwann cell plasticity after spinal cord injury shown by neural crest lineage tracing |
Q53476981 | Schwann cell precursors transplanted into the injured spinal cord multiply, integrate and are permissive for axon growth. |
Q50683619 | Schwann cell transplantation improves reticulospinal axon growth and forelimb strength after severe cervical spinal cord contusion. |
Q48193521 | Schwann cells generated from neonatal skin-derived precursors or neonatal peripheral nerve improve functional recovery after acute transplantation into the partially injured cervical spinal cord of the rat. |
Q28743246 | Schwann-spheres derived from injured peripheral nerves in adult mice--their in vitro characterization and therapeutic potential |
Q34679913 | Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. |
Q34206417 | The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration |
Q36337994 | The assessment of adeno-associated vectors as potential intrinsic treatments for brainstem axon regeneration |
Q55449341 | The role of undifferentiated adipose-derived stem cells in peripheral nerve repair. |
Q36542728 | Therapeutic interventions after spinal cord injury. |
Q30558579 | Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion |
Q52652656 | Transplantation of Adult Rat Schwann Cells into the Injured Spinal Cord. |
Q48155979 | Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery |
Q37619428 | Transplantation of neural progenitor cells in chronic spinal cord injury |
Q57838429 | Traumatic spinal cord injury |
Q53079504 | White matter repair: skin-derived precursors as a source of myelinating cells. |
Q37876560 | Will stem cell therapies be safe and effective for treating spinal cord injuries? |
Q28087189 | iPS cell transplantation for traumatic spinal cord injury |
Search more.